The VRI includes 150 researchers working on more than 40 international projects.
Aurelie Wiedemann is head of the Cellular Division at the Vaccine Research Institute (VRI), where she leads innovative projects at the interface of basic and clinical research. She earned her PhD in Immunology in 2006 and is a recognized expert in T-cell responses and clinical trial immunomonitoring. She has established laboratories in Africa for projects involving Ebola survivors and for the evaluation of Ebola vaccine candidates. Her work focuses on characterizing the immune profile of vaccinated or infected individuals with emerging and re-emerging pathogens such as HIV, SARS-CoV-2, Ebola, and Mpox. She coordinates several national and international projects and serves as a work package leader in European projects, reinforcing VRI’s role as a key player in translational immunology.